{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:45:16Z","timestamp":1649202316861},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pfizer Inc"},{"name":"Department of Veterans Affairs, Veterans Health Administration, Office of Research Development"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.pnpbp.2010.11.018","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T09:38:58Z","timestamp":1290591538000},"page":"246-251","source":"Crossref","is-referenced-by-count":1,"title":["A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients"],"prefix":"10.1016","volume":"35","author":[{"given":"E. Cabrina","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"DeJesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry K.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Cuffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kafi N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasant","family":"Dhopesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley N.","family":"Caroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 7","key":"10.1016\/j.pnpbp.2010.11.018_bb0005","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.11.018_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","author":"American Diabetes Association","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.11.018_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/028134300750018963","article-title":"Factors influencing GPs' decisions on the treatment of hypercholesterolaemic patients","volume":"18","author":"Backlund","year":"2000","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.schbul.a006927","article-title":"The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome","volume":"28","author":"Buchanan","year":"2002","journal-title":"Schizophr Bull"},{"issue":"4","key":"10.1016\/j.pnpbp.2010.11.018_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v67n0408","article-title":"Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs","volume":"67","author":"Correll","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.schbul.a006920","article-title":"Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles","volume":"28","author":"Covell","year":"2002","journal-title":"Schizophr Bull"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.11.018_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.schbul.a006911","article-title":"Editor's introduction: antipsychotic prescribing practices","volume":"28","author":"Essock","year":"2002","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2010.11.018_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1192\/bjp.138.2.100","article-title":"An experimental study of the clinical judgment of general physicians in evaluating and prescribing for depression","volume":"138","author":"Fisch","year":"1981","journal-title":"Br J Psychiatry"},{"issue":"7273","key":"10.1016\/j.pnpbp.2010.11.018_bb0050","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.pnpbp.2010.11.018_bb0055","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/appi.ajp.161.7.1301","article-title":"Medical decision making in antipsychotic drug choice for schizophrenia","volume":"161","author":"Hamann","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.pnpbp.2010.11.018_bb0060","first-page":"11","article-title":"Schizophrenia and comorbid metabolic disorders","volume":"66","author":"Henderson","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2010.11.018_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2005.06.004","article-title":"Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions","volume":"40","author":"Hoblyn","year":"2006","journal-title":"J Psychiatr Res"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.11.018_bb0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00422221","article-title":"Methods for assessing relative importance in preference based outcome measures","volume":"2","author":"Kaplan","year":"1993","journal-title":"Qual Life Res"},{"issue":"281","key":"10.1016\/j.pnpbp.2010.11.018_bb0075","first-page":"935","article-title":"Clinical judgment analysis","volume":"76","author":"Kirwan","year":"1990","journal-title":"Q J Med"},{"issue":"12","key":"10.1016\/j.pnpbp.2010.11.018_bb0080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pnpbp.2010.11.018_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.jcp.0000219917.88810.55","article-title":"Why do physicians switch from one antipsychotic agent to another? The \"physician drug stereotype\"","volume":"26","author":"Linden","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/oxfordjournals.schbul.a006915","article-title":"Can clinical practice guide a research agenda?","volume":"28","author":"Marder","year":"2002","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oxfordjournals.schbul.a006926","article-title":"The Mount Sinai conference on the pharmacotherapy of schizophrenia","volume":"28","author":"Marder","year":"2002","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"issue":"10","key":"10.1016\/j.pnpbp.2010.11.018_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4088\/JCP.v60n1002","article-title":"The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms","volume":"60","author":"Miller","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2010.11.018_bb0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/JCP.0b013e31819294cb","article-title":"Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients","volume":"29","author":"Morrato","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2010.11.018_bb0115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2337\/dc08-1720","article-title":"Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes","volume":"32","author":"Morrato","year":"2009","journal-title":"Diab Care"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2010.11.018_bb0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00114-2","article-title":"A review of the effect of atypical antipsychotics on weight","volume":"28","author":"Nasrallah","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"20","key":"10.1016\/j.pnpbp.2010.11.018_bb0125","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.290.20.2693","article-title":"Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial","volume":"290","author":"Rosenheck","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pnpbp.2010.11.018_bb0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2010.11.018_bb0135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.2006.163.4.611","article-title":"Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic","volume":"163","author":"Stroup","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2010.11.018_bb0140","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.4088\/JCP.1106e15","article-title":"The art and science of switching of antipsychotic medications, part 1","volume":"67","author":"Weiden","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"18","key":"10.1016\/j.pnpbp.2010.11.018_bb0145","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610004331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610004331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:20:23Z","timestamp":1544116823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610004331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0278584610004331"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.11.018","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}